From 2019 to 2020, there was an increase in benzodiazepine overdose emergency department visits and in benzodiazepine deaths, according to research published in the Aug. 27 issue of the U.S. CDC and Prevention Morbidity and Mortality Weekly Report.
Future Market Insight's projections reveal that the global injectable benzodiazepine market is set to shoot up significantly in 2020, reaching a value of US$ 260 Mn in the wake of the coronavirus pandemic.
Overall, 12.6 percent of U.S. adults report past-year benzodiazepine use, with misuse accounting for 17.2 percent of overall use, according to a study published online Dec. 17 in Psychiatric Services.